-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WQRqVgn2Lz0XZM1UrjpmusaL3L44QROQplfgAn8Vbp+TjfmKhu7uZVinweVBh4wj l+m1Cep9yW+1lSlbu5BoIw== 0001193805-03-000351.txt : 20030502 0001193805-03-000351.hdr.sgml : 20030502 20030502134416 ACCESSION NUMBER: 0001193805-03-000351 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030430 FILED AS OF DATE: 20030502 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: EDELMAN JOSEPH CENTRAL INDEX KEY: 0001164426 RELATIONSHIP: OWNER FILING VALUES: FORM TYPE: 4 MAIL ADDRESS: STREET 1: C/O FIRST NEW YORK SECURITIES, LLC STREET 2: 850 THIRD AVENUE, 8TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CYPRESS BIOSCIENCE INC CENTRAL INDEX KEY: 0000716054 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 222389839 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12943 FILM NUMBER: 03679071 BUSINESS ADDRESS: STREET 1: 4350 EXECUTIVE DRIVE,SUITE 325 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 2062989400 MAIL ADDRESS: STREET 1: 401 QUEEN ANNE AVE NORTH CITY: SEATTLE STATE: WA ZIP: 98109 FORMER COMPANY: FORMER CONFORMED NAME: IMRE CORP DATE OF NAME CHANGE: 19920703 4 1 e300357_edelman-4.txt STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP ----------------------------- OMB APPROVAL ----------------------------- OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response ...... 1.0 ----------------------------- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 |_| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). - -------------------------------------------------------------------------------- 1. Name and Address of Reporting Person* Edelman Joseph - -------------------------------------------------------------------------------- (Last) (First) (Middle) c/o First New York Securities 850 Third Avenue, 8th Floor - -------------------------------------------------------------------------------- (Street) New York NY 10022 - -------------------------------------------------------------------------------- (City) (State) (Zip) - -------------------------------------------------------------------------------- 2. Issuer Name and Ticker or Trading Symbol Cypress Bioscience, Inc. (CYPB) - -------------------------------------------------------------------------------- 3. I.R.S. Identification Number of Reporting Person, if an entity (voluntary) - -------------------------------------------------------------------------------- 4. Statement for Month/Day/Year 4/2/03 - 4/30/03 - -------------------------------------------------------------------------------- 5. If Amendment, Date of Original (Month/Day/Year) - -------------------------------------------------------------------------------- 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) |_| Director |X| 10% Owner |_| Officer (give title below) |_| Other (specify below) ______________________________ - -------------------------------------------------------------------------------- 7. Individual or Joint/Group Filing (Check Applicable Line) |_| Form filed by One Reporting Person |X| Form filed by More than One Reporting Person - -------------------------------------------------------------------------------- (Over) ================================================================================ Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned ================================================================================
5. 6. 4. Amount of Owner- Securities Acquired (A) or Securities ship 2A. 3. Disposed of (D) Beneficially Form: 7. 2. Deemed Transaction (Instr. 3, 4 and 5) Owned Following Direct Nature of Transaction Execution Code -------------------------- Reported (D) or Indirect 1. Date Date, if any (Instr. 8) (A) Transaction(s) Indirect Beneficial Title of Security (Month/Day/ (Month/Day/ ----------- or (Instr. 3 (I) Ownership (Instr. 3) Year) Year) Code V Amount (D) Price and 4) (Instr.4) (Instr. 4) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/2/03 (3) S 5,000 D $2.51 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/3/03 (3) S 5,000 D $2.52 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/4/03 (3) S 5,400 D $2.5344 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/4/03 (4) S 100 D $2.5344 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/7/03 (3) S 1,900 D $2.575 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/7/03 (4) S 100 D $2.575 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/8/03 (3) S 9,900 D $2.533 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/8/03 (4) S 100 D $2.533 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/9/03 (3) S 12,900 D $2.5662 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/9/03 (4) S 100 D $2.5662 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/10/03 (3) S 1,000 D $2.60 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/11/03 (3) S 3,100 D $2.60 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/15/03 (3) S 1,000 D $2.60 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/15/03 (3) S 4,000 D $2.70 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/16/03 (3) S 13,300 D $2.7515 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/16/03 (4) S 300 D $2.7515 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/17/03 (3) S 13,300 D $2.6579 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/17/03 (4) S 100 D $2.6579 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/21/03 (3) S 22,300 D $2.5223 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/21/03 (4) S 200 D $2.5223 6,800 (2) (2) Through FNYT (2) - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/22/03 (3) S 15,000 D $2.5113 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/23/03 (3) S 3,500 D $2.5143 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/28/03 (3) S 100 D $2.2233 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/28/03 (3) S 49,900 D $2.2233 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/29/03 (3) S 55,000 D $2.4096 - ------------------------------------------------------------------------------------------------------------------------------------ Common Stock, $0.02 par value 4/30/03 (3) S 4,300 D $2.63 1,294,763 (1) (1) By Master Fund (1) ====================================================================================================================================
(Over) FORM 4 (continued) ================================================================================ Table II -- Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) ================================================================================
9. Number 10. of Owner- 7. Deriv- ship 2. 5. Title and ative Form of Conver- Number of Amount of Secur- Deriv- 11. sion Derivative Underlying ities ative Nature or 3A. Securities 6. Securities 8. Bene- Secur- of Exer- Deemed 4. Acquired Date (Instr. 3 Price ficially ities: In- cise 3. Execu- Trans- (A) or Exercisable and and 4) of Owned Direct direct Price Trans- tion action Disposed Expiration Date ------------- Deriv- Following (D) or Bene- 1. of action Date, Code of (D) (Month/Day/Year) Amount ative Reported In- ficial Title of Deriv- Date if any (Instr. (Instr. 3, ---------------- or Secur- Transac- direct Owner- Derivative ative (Month/ (Month/ 8) 4 and 5) Date Expira- Number ity tion(s) (I) ship Security Secur- Day/ Day/ ------ ---------- Exer- tion of (Instr. (Instr. (Instr. (Instr. (Instr. 3) ity Year) Year) Code V (A) (D) cisable Date Title Shares 5) 4) 4) 4) - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------
Explanation of Responses: (1) These securities are held by Perceptive Life Sciences Master Fund Ltd.("Master Fund") of which Perceptive Advisors LLC ("Advisors") is the investment advisor. As investment advisor of Master Fund, Advisors has the sole power to vote and dispose of the securities held by Master Fund which power is exercisable by Joseph Edelman as the managing member of Advisors. In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by Master Fund is reported herein. Mr. Edelman and Advisors each disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, any beneficial ownership of any of the Issuer's securities that are held by Master Fund, except to the extent of its indirect pecuniary interest therein, and this report shall not be deemed an admission that Mr. Edelman or Advisors is the beneficial owner of such securities for purposes of Section 16 or for any other purposes. (2) These securities are held in an account of First New York Trading, LLC ("FNYT"), of which account Mr. Edelman has sole voting and dispositive power. In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held in the FNYT account is reported herein. Mr. Edelman disclaims Section 16 beneficial ownership over such securities except to the extent of his indirect pecuniary interest therein. In addition, neither Master Fund nor Advisors has any pecuniary interest in the securities that are held in the FNYT account. (3) These transactions were effected by Master Fund. (4) There transactions were effected through the FNYT Account. /s/ Joseph Edelman 5/1/03 - --------------------------------------------- ----------------------- Joseph Edelman Date **Signature of Reporting Person Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4(b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. Page 2 Joint Filer Information Names: Perceptive Life Sciences Master Fund Ltd. and Perceptive Advisors LLC IRS I.D. No.: 980338943 (Master Fund) 52-2291758 (Advisors) Address: c/o First New York Securities, LLC 850 Third Avenue, 8th Floor New York, New York 10022 Designated Filer: Joseph Edelman Issuer and Ticker Symbol: Cypress Bioscience, Inc. (CYPB) Statement for Month/Day/Year 4/2/03-4/30/03 The undersigned, Perceptive Life Sciences Master Fund Ltd. and Perceptive Advisors LLC are jointly filing the attached Initial Statement of Beneficial Ownership on Form 4 with Joseph Edelman with respect to the beneficial ownership of securities of Cypress Bioscience, Inc. PERCEPTIVE LIFE SCIENCES PERCEPTIVE ADVISORS LLC MASTER FUND LTD. By: Perceptive Advisors LLC, its investment advisor By: /s/ Joseph Edelman By: /s/ Joseph Edelman ---------------------------- ---------------------------- Name: Joseph Edelman Name: Joseph Edelman Title: Managing Member Title: Managing Member -----END PRIVACY-ENHANCED MESSAGE-----